vs
Gorilla Technology Group Inc.(GRRR)与RIGEL PHARMACEUTICALS INC(RIGL)财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是Gorilla Technology Group Inc.的1.8倍($69.8M vs $39.3M),RIGEL PHARMACEUTICALS INC净利率更高(384.0% vs -21.6%,领先405.7%),Gorilla Technology Group Inc.同比增速更快(90.2% vs 21.2%)
Gorilla Technology Group Inc.是一家全球AI技术解决方案供应商,核心业务涵盖智能视频分析、智慧城市平台及网络安全产品,面向亚太、北美、欧洲等地区的政府机构、企业客户与商业合作伙伴提供服务,助力客户提升运营效率与安全保障能力。
Rigel制药是一家临床阶段生物技术企业,专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法,核心市场位于美国,旗下已获批产品可治疗成人免疫性血小板减少症,致力于满足未被覆盖的临床医疗需求。
GRRR vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.8倍
$39.3M
营收增速更快
GRRR
高出69.0%
21.2%
净利率更高
RIGL
高出405.7%
-21.6%
损益表 — Q2 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $39.3M | $69.8M |
| 净利润 | $-8.5M | $268.1M |
| 毛利率 | 34.2% | 91.5% |
| 营业利润率 | -23.1% | 33.2% |
| 净利率 | -21.6% | 384.0% |
| 营收同比 | 90.2% | 21.2% |
| 净利润同比 | -627.6% | 1769.2% |
| 每股收益(稀释后) | $-0.43 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
GRRR
RIGL
| Q4 25 | — | $69.8M | ||
| Q3 25 | — | $69.5M | ||
| Q2 25 | $39.3M | $101.7M | ||
| Q1 25 | — | $53.3M | ||
| Q4 24 | — | $57.6M | ||
| Q3 24 | — | $55.3M | ||
| Q2 24 | $20.7M | $36.8M | ||
| Q1 24 | — | $29.5M |
净利润
GRRR
RIGL
| Q4 25 | — | $268.1M | ||
| Q3 25 | — | $27.9M | ||
| Q2 25 | $-8.5M | $59.6M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | — | $12.4M | ||
| Q2 24 | $1.6M | $-1.0M | ||
| Q1 24 | — | $-8.2M |
毛利率
GRRR
RIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | 34.2% | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | 85.5% | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率
GRRR
RIGL
| Q4 25 | — | 33.2% | ||
| Q3 25 | — | 40.9% | ||
| Q2 25 | -23.1% | 60.1% | ||
| Q1 25 | — | 23.9% | ||
| Q4 24 | — | 28.9% | ||
| Q3 24 | — | 25.4% | ||
| Q2 24 | 8.6% | 1.2% | ||
| Q1 24 | — | -23.6% |
净利率
GRRR
RIGL
| Q4 25 | — | 384.0% | ||
| Q3 25 | — | 40.2% | ||
| Q2 25 | -21.6% | 58.6% | ||
| Q1 25 | — | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | — | 22.5% | ||
| Q2 24 | 7.8% | -2.8% | ||
| Q1 24 | — | -27.9% |
每股收益(稀释后)
GRRR
RIGL
| Q4 25 | — | $14.11 | ||
| Q3 25 | — | $1.46 | ||
| Q2 25 | $-0.43 | $3.28 | ||
| Q1 25 | — | $0.63 | ||
| Q4 24 | — | $0.82 | ||
| Q3 24 | — | $0.70 | ||
| Q2 24 | $0.15 | $-0.06 | ||
| Q1 24 | — | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $10.1M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $98.2M | $391.5M |
| 总资产 | $162.7M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势,按日历期对齐
现金及短期投资
GRRR
RIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | $10.1M | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | $11.2M | $49.1M | ||
| Q1 24 | — | $49.5M |
总债务
GRRR
RIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | $7.4M | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益
GRRR
RIGL
| Q4 25 | — | $391.5M | ||
| Q3 25 | — | $117.6M | ||
| Q2 25 | $98.2M | $81.9M | ||
| Q1 25 | — | $18.6M | ||
| Q4 24 | — | $3.3M | ||
| Q3 24 | — | $-14.6M | ||
| Q2 24 | $72.1M | $-29.9M | ||
| Q1 24 | — | $-31.7M |
总资产
GRRR
RIGL
| Q4 25 | — | $513.6M | ||
| Q3 25 | — | $242.5M | ||
| Q2 25 | $162.7M | $206.7M | ||
| Q1 25 | — | $176.0M | ||
| Q4 24 | — | $164.0M | ||
| Q3 24 | — | $139.4M | ||
| Q2 24 | $133.1M | $128.4M | ||
| Q1 24 | — | $126.5M |
负债/权益比
GRRR
RIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.10× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-12.5M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-12.8M | — |
| 自由现金流率自由现金流/营收 | -32.7% | — |
| 资本支出强度资本支出/营收 | 0.8% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
GRRR
RIGL
| Q4 25 | — | $22.0M | ||
| Q3 25 | — | $24.0M | ||
| Q2 25 | $-12.5M | $30.5M | ||
| Q1 25 | — | $-893.0K | ||
| Q4 24 | — | $14.5M | ||
| Q3 24 | — | $21.7M | ||
| Q2 24 | $-11.3M | $302.0K | ||
| Q1 24 | — | $-5.0M |
自由现金流
GRRR
RIGL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-12.8M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-11.6M | — | ||
| Q1 24 | — | — |
自由现金流率
GRRR
RIGL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -32.7% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -56.2% | — | ||
| Q1 24 | — | — |
资本支出强度
GRRR
RIGL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.8% | — | ||
| Q1 24 | — | — |
现金转化率
GRRR
RIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | -6.99× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图